Ticker Details
Nurix Therapeutics, Inc.
IPO Date:	July 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.45%
Avg Daily Range (30 D):	$0.32 | 1.95%
Avg Daily Range (90 D):	$0.37 | 2.23%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.87M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	2,042
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$1.94M
Avg Institutional Trade (90 D):	$2.45M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.03M
Avg Closing Trade (30 D):	$2.32M
Avg Closing Trade (90 D):	$2.78M
Avg Closing Volume:	119.42K

News

May 13, 2026 @ 11:00 AM Nurix Therapeutics to Participate in Upcoming Inve... Source: Not Specified

Apr 22, 2026 @ 11:00 AM Nurix Therapeutics Announces New Preclinical Data ... Source: Na

Apr 21, 2026 @ 5:00 PM Follicular Lymphoma Clinical Trial Space Intensifi... Source: Delveinsight

Apr 8, 2026 @ 10:00 AM Nurix Therapeutics Reports First Quarter 2026 Fina... Source: Na

Feb 22, 2026 @ 6:12 PM Nurix Stock Is Down 6% This Past Year, but One Bio... Source: Jonathan Ponciano

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-3.17	$-.79
Diluted EPS	$-3.17	$-.79
Revenue	$71.78M	$6.25M
Gross Profit
Net Income / Loss	$-295.28M	$-87.17M
Operating Income / Loss	$-315.3M	$-92.5M
Cost of Revenue
Net Cash Flow	$-4.65M	$-175.77M
PE Ratio